Sox9 is required for the early differentiation of the prostate bud epithelia, and fully involved in the carcinogenesis, differentiation, and invasion prostate cancer through reactivating the WNT/beta-catenin signaling that mediates ductal morphogenesis [25–28]. Here, SOX9 is linked to prostate carcinoma.